Orthofix Archives - Page 4 of 5 - Medical Design Sourcing

Intersect ENT CEO joins Orthofix board

Orthofix (NSDQ:OFIX) announced today that Intersect ENT (NSDQ:XENT) executive Thomas A. West has joined its board of directors.

Lewisville, Texas-based Orthofix named West to its board and appointed him to its Compensation and Talent Development Committee.

West currently serves as President, CEO & Director of Intersect ENT, which develops drug-delivery devices for ear, nose and throat procedures. He has navigated the company through its recently announced $1.1 billion acquisition by Medtronic.

Before Intersect ENT, West was Division President of Diagnosis Solutions at Hologic. Before that, he had a 23-year stint at Johnson & Johnson in various domestic and international roles. West’s most recent position was Worldwide VP of Strategy & Business Development a Diabetes Solutions Companies.

“Tom joins the Orthofix Board of Directors with more than 30 years of global experience in the medical device industry,” Orthofix Chair of the Bo…

Orthofix ticks up on Street-beating Q2 results

Orthofix (NSDQ:OFIX) posted second-quarter results today that beat the overall consensus on Wall Street.

The Lewisville, Texas-based company reported profits of $2.4 million, or 12¢ per share, on sales of $121.4 million, for the three months ended June 30 for a sales growth of 65.99% compared with Q2 2020.

Adjusted to exclude one-time items, earnings per share were 32¢, 21¢ ahead of The Street, where analysts were looking for sales of $108.2 million.

“We are proud of our second-quarter performance, in which we delivered accelerated topline growth sequentially and over pre-COVID levels,” president and CEO Jon Serbousek said in a news release. “We continue to see the positive impacts of our strategic initiatives, including increased product adoption driven through our expanded pool of strategic distribution partners, as well as ongoing strength from new products, in particular our M6-C artificial cervical disc and the Fitbone lengthening nail.”

“Int…

Orthofix launches Fiberfuse Strip bone graft

Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S.

Lewisville, Texas-based Orthofix designed the FiberFuse Strip to be a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures.

Get the full story on our sister site, Medical Design & Outsourcing.

Orthofix launches Fiberfuse Strip bone graft

Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S.

Lewisville, Texas-based Orthofix designed the FiberFuse Strip to be a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures.

FiberFuse Strip is 100% bone and has a unique mixture of mineralized cancellous and demineralized cortical bone with no carrier added. It creates a natural scaffold to allow for revascularization, cellular ingrowth and new bone formation.

“We are pleased to introduce this next-generation formulation in the FiberFuse allograft line,” Orthofix global spine president Kevin Kenny said in a news release. “The FiberFuse Strip delivers a high-quality advanced bone-graft option in a convenient, easy-to-use strip preparation. This technology advancement was developed as part of our strategy to provide procedurally-focused solutions for spine surgeons and their patients.”

MTF Biologics i…

Orthofix announces U.S. launch, first patient implant of 3D-printed spacer system

Orthofix (NSDQ:OFIX) announced today that it launched and implanted the first 3D-printed Forza Ti PLIF spacer system in the U.S.

Lewisville, Texas-based Orthofix’s 3D-printed Forza Ti posterior lumbar interbody fusion (PLIF) spacer system uses the company’s Nanovate technology to comprise a titanium lumbar interbody device that allows the bone to grow into and through the spacer, according to a news release.

Orthofix touts features of the Forza Ti system that include a large open graft window for packing bone-grafting material, a bulleted nose to assist with distraction and 3D-printed porous titanium with macro, micro and nanoscale surface features.

Additionally, the system includes a nanoscale surface proven to increase proliferation and alkaline phosphatase activity in human stem cells in vitro, as well as a functional gradient porous structure with 80% porosity at the midline of the implant to allow for increased fluoroscopic visualization…

Orthofix launches Oscar Pro arthroplasty system

Orthofix (NSDQ:OFIX) today said it fully launched its Oscar Pro ultrasonic arthroplasty revision system in the U.S. and Europe.

The ultrasonic surgical system is designed to aid in the removal of cement during complex joint revision surgeries.

Oscar Pro’s new design includes an enhanced user interface to enable a more efficient surgical experience and new data collection capabilities. The system uses ultrasonic vibrations to soften cement holding implants in place. It also has a tool that allows surgeons to remove the softened cement using specially designed probes.

“The Oscar Pro system is a fourth-generation product from the OSCAR line that has been the gold standard in assisting with complex joint revision surgeries since 1990,” Orthofix president of global orthopedics Paul Gonsalves said in a news release. “The technology is well accepted and has been used successfully for decades in removing cement total joint arthroplasties and aiding c…

Orthofix beats The Street in Q1 results

Orthofix (NSDQ:OFIX) posted first-quarter results today that beat the consensus forecast on Wall Street.

The Lewisville, Texas-based company reported losses of -$5.8 million, or -30¢ per share, on sales of $105.6 million for the three months ended March 31, for a sales growth of 0.73% compared with Q1 2020.

Adjusted to exclude one-time items, earnings per share were 17¢, 15¢ ahead of The Street, where analysts were looking for sales of $95.6 million.

“We are excited about the topline performance of the business during the first quarter, particularly as we continued to contend with the headwinds of the global pandemic and the added challenges of the recent severe winter weather-related disruption,” president and CEO Jon Serbousek said in a news release. “We are pleased with the positive revenue impact from initiatives we put into place in 2020, including a focus on new product introductions and the development of our U.S. commercial channel. Both our M6-C…

Orthofix signs exclusive licensing agreement for Igea’s bone and joint stimulation devices

Orthofix (NSDQ:OFIX) today said it entered an exclusive license agreement to commercialize Igea’s bone, cartilage and soft tissue stimulation products in the U.S. and Canada.

Through the agreement, Orthofix has the rights to pursue FDA approvals and commercialization of Italy-based Igea’s platform of orthopedic products. The products will also be marketed under the Orthofix brand and will expand the company’s bone growth therapies portfolio of pulsed electromagnetic field (PEMF) products with other indications for low-intensity pulsed ultrasound (LIPUS) and capacitive coupling (CC) for fracture management.

“Orthofix is the U.S. market leader with our PEMF technology bone growth stimulation systems indicated for post-operative spinal fusions and treating bone fractures that have not healed after surgery, and Igea is the European market and technology leader for bone and joint stimulation,” Orthofix president and CEO Jon Serbousek said in a news…

The 10 largest orthopedic device companies in the world

[Image from Pixaby]Pent-up demand could make orthopedic devices a hot space in 2021.

The COVID-19 pandemic was especially brutal for the orthopedic device industry. Many of the largest companies in the space saw double-digit percentage declines in revenue in 2020. Health providers delayed or canceled elective procedures to focus on the pandemic, and patients stayed away in droves.

It’s a new year now, though, and vaccines are rolling out. People don’t want to live with a bad knee or hip or back forever. Growth will eventually return for the industry, and orthopedic device companies are positioning themselves to be ready.

Rather than hunkering down during the pandemic, many ortho device companies chose shop for new technologies and major M&A deals. They’re reorganizing and launching new products ranging from surgical robots to smart implants.

Read on and discover the latest about the world’s 10 largest orthopedic device companies.

Next>>

The 10 largest orthopedic device companies in the world

[Image from Pixaby]

Pent-up demand could make orthopedic devices a hot space in 2021.

The COVID-19 pandemic was especially brutal for the orthopedic device industry. Many of the largest companies in the space saw double-digit percentage declines in revenue in 2020. Health providers delayed or canceled elective procedures to focus on the pandemic, and patients stayed away in droves.

It’s a new year now, though, and vaccines are rolling out. People don’t want to live with a bad knee or hip or back forever. Growth will eventually return for the industry, and orthopedic device companies are positioning themselves to be ready.

Rather than hunkering down during the pandemic, many ortho device companies chose shop for new technologies and major M&A deals. They’re reorganizing and launching new products ranging from surgical robots to smart implants.

Read on and discover the latest about the w…

Orthofix wins FDA clearance for 3D printed TLIF spacer system

Orthofix (NSDQ:OFIX) today said it received FDA 510(k) clearance for its Forza Ti TLIF spacer system.

The Forza Ti spacer is designed to optimize transforaminal lumbar interbody fusion (TLIF) procedures, according to the company. It has a titanium 3D-printed interbody with porosity and surface that allows bones to grow into and through the spacer.

Interbody implants are typically inserted between the vertebrae during a spinal fusion surgery to help relieve pressure on nerves and to hold the vertebrae in place while fusion occurs.

“The 3D-printed surface technology, titanium material, and implant design all play a role in the bone growth process during fusion,” Gary Rosenberg, an orthopedic spine surgeon operating at Orange County Global Medical Center in Santa Ana, Calif. who performed the first Forza Ti TLIF spacer patient implant procedure, said in a news release. “The intuitive instrumentation allows for easy insertion, and the optimized porosity and …

FDA clears Orthofix 3D-printed titanium cervical spacer system

Orthofix Medical (NSDQ:OFIX) announced today that it received FDA 510(k) clearance for its Construx Mini Ti spacer system.

Lewisville, Texas-based Orthofix also administered the first patient implant of the 3D-printed Construx Mini Ti system, which is designed to enhance anterior cervical discectomy and fusion (ACDF) procedures, according to a news release.

The Construx Mini Ti cervical spacer includes Nanovate technology is touted as the first 3D-printed titanium interbody implant to be introduced onto the market by Orthofix.

Endplates of the implants showed a significant increase in growth factors involved in osteogenesis and osteoblast maturation, resulting in more favorable osteogenic environment for bone ingrowth, Orthofix said.

The system includes 3D-printed porous titanium with macro, micro and nanoscale surface features, the latter of which increases proliferation and alkaline phosphatase activity in human stem cells in vitro. Additionally…